{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-032063","form_type":"8-K","ticker":"XAIR","cik":"0001641631","company_name":"Beyond Air, Inc.","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.538248+00:00","generated_at":"2026-06-21T20:27:00.972544+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Beyond Air Q2 net loss $12.0M ($0.40/sh); LungFit PH launch; UNO combo data positive","bullets":["Net loss attributable to shareholders $12.0M ($0.40 per share) for Q2 FY2023 ended Sep 30, 2022.","Cash and equivalents $72.5M as of Sep 30; cash burn $10.4M in quarter, within guidance of $8-10M.","LungFit PH commercial launch progressing; CE Mark expected end of 2022; PMA supplement for cardiac label expansion planned.","Preclinical data shows UNO + anti-PD-1 leads to higher tumor regression and prolonged survival in CT26 mice.","Beyond Cancer Phase 1 solid tumor study first patient dosed Aug 2022; topline data expected H1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-032063","json":"https://secwatch.observer/filing/0001493152-22-032063.json","markdown":"https://secwatch.observer/filing/0001493152-22-032063.md","text":"https://secwatch.observer/filing/0001493152-22-032063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641631/000149315222032063/0001493152-22-032063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641631/000149315222032063/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T20:27:00.972544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a8ee1f4d28d0636a8441a618a0f8fffae057175e","claim":"Beyond Air, Inc. reported fiscal quarter ended September 30, 2022 results: net income $12.8 million, EPS ($0.40) per share.","evidence_excerpt":"For the fiscal quarter ended September 30, 2022, Beyond Air, Inc. (the “Company”) had a net loss of $12.8 million, of which $12.0 million, or ($0.40) per share, was attributable to the shareholders of Beyond Air, compared with a net loss of $8.7 million, or ($0.36) per share, for the fiscal quarter ended September 30, 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315222032063/0001493152-22-032063-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal quarter ended September 30, 2022"},{"label":"Net income","value":"$12.8 million"},{"label":"EPS","value":"($0.40) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}